According to a meta-analysis that was published last week by Cochrane, marijuana may be able to reduce neuropathic pain, but not by a lot and not by much more than a placebo would.

The authors of the meta-analysis had evaluated 16 randomized, double-blind, placebo-controlled clinical trials. There were a total of 1,750 people that tested a variety of marijuana-derived compounds either against placebos or a pain killer.

20% of the people had cut their pain in half using cannabis while 17% of the people did the same with a placebo. 10% of the people withdrew from the trials due to the side effects.

Dr. Sachin Patel, a psychiatry professor and researcher at the Vanderbilt University Medical Center remarked to Newsweek, “There really is a lack of good, high-quality evidence about cannabis and cannabis products as they relate to therapeutic benefits in pain.”

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Ohio Senator Wants Marijuana Dropped From Controlled Substances List
22 July 2017
Second Person Charged in Infant Smoking Marijuana Case
29 March 2018
Ohio Starts Accepting Marijuana License Applications from Doctors
23 March 2018